Company Overview of XEME Biopharma Inc.
XEME Biopharma Inc. develops and manufactures personalized therapeutic cancer vaccines for humans and veterinary uses. It offers personalized therapeutic vaccines for lymphoma, chronic lymphocytic leukemia, and ovarian cancers; and non-personalized therapeutic vaccines for colorectal and prostate cancers. The company was founded in 2005 and is based in Lombard, Illinois. XEME Biopharma Inc. operates as a subsidiary of TheraTest Laboratories, Inc.
1120 North Dupage Avenue
Lombard, IL 60148
Founded in 2005
Key Executives for XEME Biopharma Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
April 4, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact XEME Biopharma Inc., please visit www.xemebiopharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.